Multiplex mIHC: making discoveries in multicolor
Tumor microenvironment (TME) expression profiles guide our understanding of the interactions between malignant and non-malignant cells. Multiplex immunofluorescence enables the tracking of multiple markers within the TME, which improves therapeutic response predictions and identifies potential new therapeutic targets.
This poster explores multiplex immunofluorescence, how it differs from traditional immunohistochemistry applications and the advantages of this method.
This poster explains:
- What multiplex immunofluorescence is
- How multiplex immunofluorescence differs from other traditional immunohistochemistry applications
- Advantages of multiplex immunofluorescence for immuno-oncology research
This content was provided by
Follow Fortis Life Sciences on Twitter and on LinkedIn.
Submit Your Research to the F1000Research Oncology Gateway
Share your oncology research with the global scientific community through the F1000Research Oncology Gateway. With trusted publishing, open access, and transparent peer review, your work will uphold the highest standards of research integrity while driving innovation in cancer treatment and understanding.
Join a trusted platform that accelerates progress in oncology. Submit your research today at F1000Research Oncology Gateway.
